BSE filing, NSE: COLINZ. Summary written from the filing by ALFA Finder's alert engine.
Colinz Laboratories Ltd: key numbers
- Share price
- ₹69.25
- Market cap
- ₹17.44 Cr
- Revenue (annual)
- ₹6.14 Cr
- Net profit (annual)
- ₹0.51 Cr
- P/E (TTM)
- 6.3×Sector 47.2×
- Promoter holding
- 50.60%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Colinz Laboratories Ltd
All →Colinz Laboratories Q2 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% YoY
Colinz Laboratories reported unaudited half-year profit of Rs 252.77 lakh to September 2026. The period includes a Rs 276.33 lakh exceptional gain on asset sale.
- Key figure
- Net profit ₹0.1 Cr · +0.0% YoY
Colinz Laboratories Board Meeting Date
Colinz Laboratories scheduled a board meeting for October 29, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Colinz Laboratories Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Colinz Laboratories Other Announcement
Colinz Laboratories Ltd submitted a non-applicability declaration for Related Party Transaction disclosures for the quarter ended September 30, 2026. The company claims exemption under Regulation 15(2).
Colinz Laboratories Annual General Meeting
Colinz Laboratories held its 40th Annual General Meeting on September 22, 2026, where shareholders considered financial statements and director appointments.
Colinz Laboratories Open Offer: ₹3.54 Cr
Colinz Laboratories Ltd issued a Post Offer Advertisement for an Open Offer. The offer closed with only 6 shares tendered out of a proposed 6,54,966 shares.
- Value
- ₹3.54 Cr
Other board meeting outcome announcements
All →Cubical Financial Services Board Meeting Outcome
Cubical Financial Services' board approved establishing a new corporate office in North Delhi. No monetary amount or capacity is stated.
Atmastco Board Meeting Outcome
Atmastco Limited's board approved the notice of its 32nd AGM on 25 November 2026, the FY2025-26 Annual Report, a scrutinizer and e-voting arrangements. No material business decision or monetary amount is reported.
Indrayani Biotech Board Meeting Outcome
Indrayani Biotech appointed Ms. N. S. Poornima as Secretarial Auditor for FY 2025-26 to fill a casual vacancy. Company Secretary C.S. Shanmuga Sundar's resignation took effect on 2 November 2026.
Borana Weaves Board Meeting Outcome
Borana Weaves' board approved shifting its registered office to Surat, Gujarat, effective immediately. The change is an administrative address update with no business impact.
Emergent Industrial Solutions Board Meeting Outcome
Emergent Industrial Solutions reconstituted its four board committees, reassigning existing directors across Audit, Nomination, Stakeholders Relationship, and CSR roles. This is routine governance with no financial impact.
Winsol Engineers Board Meeting Outcome
Winsol Engineers' board approved AoA changes to allow voluntary dividend waiver and postal ballot logistics. All decisions are routine governance matters with no material business impact.